EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. Eyebright Medical Technology (Beijing) Co., Ltd. Stock
Equities
688050
CNE1000041J5
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.6 CNY | -2.67% |
|
+5.92% | -21.76% |
| Sales 2024 * | 1.39B 192M | Sales 2025 * | 1.8B 249M | Capitalization | 14.17B 1.96B |
|---|---|---|---|---|---|
| Net income 2024 * | 353M 48.76M | Net income 2025 * | 570M 78.73M | EV / Sales 2024 * | 9.94 x |
| Net cash position 2024 * | 329M 45.38M | Net cash position 2025 * | 646M 89.2M | EV / Sales 2025 * | 7.52 x |
| P/E ratio 2024 * |
39.5
x | P/E ratio 2025 * |
25.1
x | Employees | 871 |
| Yield 2024 * |
0.39% | Yield 2025 * |
0.64% | Free-Float | 61.52% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.67% | ||
| 1 week | +5.92% | ||
| Current month | +4.50% | ||
| 1 month | -1.93% | ||
| 3 months | -14.04% | ||
| 6 months | -20.00% | ||
| Current year | -21.76% |
1 week
122.01
143.00
1 month
119.65143.00
Current year
119.65171.99
1 year
119.65228.88
3 years
119.65398.86
5 years
119.65398.86
10 years
119.65398.86
| Managers | Title | Age | Since |
|---|---|---|---|
Jiang Bing Xie
CEO | Chief Executive Officer | 52 | 10-04-20 |
Zhao Wang
FOU | Founder | 43 | 11-07-31 |
Dan Xuan Wang
CHM | Chairman | 42 | 13-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jiang Bing Xie
CEO | Chief Executive Officer | 52 | 10-04-20 |
Yu Fang
BRD | Director/Board Member | 61 | 18-03-11 |
Shao Hua Wang
BRD | Director/Board Member | 54 | 10-09-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 134.6 | -2.67% | 1,810,360 |
| 24-04-18 | 138.3 | +10.46% | 3,184,886 |
| 24-04-17 | 125.2 | +2.20% | 1,362,717 |
| 24-04-16 | 122.5 | -3.62% | 1,183,913 |
| 24-04-15 | 127.1 | +0.02% | 948,656 |
End-of-day quote Shanghai S.E., April 18, 2024
More quotes
Eyebright Medical Technology Beijing Co Ltd is a China-based company principally involved in the research, development, manufacturing and sales of ophthalmic medical devices. Its main products include ophthalmic surgery and optometry. Surgical products mainly include intraocular lens, capsular tension ring, intraocular lens implantation system, ophthalmic viscoelastic agent, various types of ophthalmic microsurgical instruments and ophthalmic scalpels, and optometry products include corneal orthopaedics (night-wear type), hard contact lens (daily-wear type) and tear test paper, among others. The Company conducts its businesses in domestic and overseas markets.
Calendar
2024-04-24
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
134.6
CNY
Average target price
214.5
CNY
Spread / Average Target
+59.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -21.76% | 2.01B | |
| -1.84% | 23.52B | |
| -9.62% | 16.27B | |
| +5.69% | 13.45B | |
| +6.62% | 9.68B | |
| +12.20% | 1.8B | |
| +30.15% | 1.62B | |
| +8.37% | 570M | |
| 0.00% | 524M | |
| +29.68% | 96.53M |
- Stock Market
- Equities
- 688050 Stock
